RFamide-related peptide (RFRP)-3 is a neuropeptide thought to play an inhibitory role in the regulation of reproduction in various mammalian species, although some stimulatory effects have been reported. To date, the effects of RFRP-3 on gonadotropin secretion have been scarcely studied in mice. The aim of the current study was to characterize the effect of RFRP-3 administration on gonadotropin secretion in male and female mice. Adult intact and castrated male mice received acute central injections of 0.5 to 5 nmol of RFRP-3, and luteinizing hormone (LH) concentration was assayed in tail-tip blood samples. RFRP-3 had a dose-dependent stimulatory effect on LH secretion when administered centrally to both intact and castrated mice, and this effect was diminished when RFRP-3 was administered to kisspeptin receptor knockout mice. In female mice, central RFRP-3 had an inhibitory effect on LH secretion when administered at the time of the preovulatory LH surge in intact mice, or of an estradiol-induced LH surge in ovariectomized mice. Conversely, central RFRP-3 administration had no effect on LH levels in intact diestrus or ovariectomized, low-dose estradiolimplanted mice. Finally, peripheral administration of RFRP-3 to intact males and to females at the time of the preovulatory LH surge or during diestrus had no effect on LH secretion. Taken together, these results provide a detailed description of sex-and cycle stage-dependent effects of RFRP-3 on gonadotrophin secretion in mice. Moreover, it appears that the stimulatory effects are mediated in part by the receptor for kisspeptin, a potent stimulator of the reproductive axis. (Endocrinology 158: 2873(Endocrinology 158: -2883(Endocrinology 158: , 2017 
RFamide-related peptide (RFRP)-3 is a neuropeptide thought to play an inhibitory role in the regulation of reproduction in various mammalian species, although some stimulatory effects have been reported. To date, the effects of RFRP-3 on gonadotropin secretion have been scarcely studied in mice. The aim of the current study was to characterize the effect of RFRP-3 administration on gonadotropin secretion in male and female mice. Adult intact and castrated male mice received acute central injections of 0.5 to 5 nmol of RFRP-3, and luteinizing hormone (LH) concentration was assayed in tail-tip blood samples. RFRP-3 had a dose-dependent stimulatory effect on LH secretion when administered centrally to both intact and castrated mice, and this effect was diminished when RFRP-3 was administered to kisspeptin receptor knockout mice. In female mice, central RFRP-3 had an inhibitory effect on LH secretion when administered at the time of the preovulatory LH surge in intact mice, or of an estradiol-induced LH surge in ovariectomized mice. Conversely, central RFRP-3 administration had no effect on LH levels in intact diestrus or ovariectomized, low-dose estradiolimplanted mice. Finally, peripheral administration of RFRP-3 to intact males and to females at the time of the preovulatory LH surge or during diestrus had no effect on LH secretion. Taken together, these results provide a detailed description of sex-and cycle stage-dependent effects of RFRP-3 on gonadotrophin secretion in mice. Moreover, it appears that the stimulatory effects are mediated in part by the receptor for kisspeptin, a potent stimulator of the reproductive axis. (Endocrinology 158: 2873-2883, 2017) G onadotrophin-releasing hormone (GnRH) released into the portal blood system is responsible for the production and release of the gonadotrophins, luteinizing hormone (LH) and follicle-stimulating hormone, which in turn drive male and female gonadal function. GnRH neurons are therefore the final hypothalamic target for hypothalamic-pituitary-gonadal (HPG) axis activity regulators, such as neurotransmitters, neuropeptides, and peripheral hormones. It is well established that steroidal regulators of GnRH release act on upstream targets in the brain to exert negative and positive feedback effects, the latter inducing the preovulatory surge of GnRH and gonadotrophins that triggers ovulation in females (1, 2) . In recent years, it has emerged that kisspeptins are key elements of the networks controlling GnRH secretion and mediating sex steroid feedback effects in the brain. Indeed, in 2003, two studies concurrently indicating that the kisspeptin receptor (KISS1R or GPR54), and therefore its ligands, are essential for normal reproduction (3, 4) prompted intensive research on the involvement of kisspeptins in the regulation of the HPG axis. However, our understanding of the interactions of kisspeptins with other regulatory signals of GnRH neurons remains incomplete.
A peptide that is structurally related to kisspeptin and also involved in the regulation of the HPG axis was discovered in 2000 (5, 6) , and termed RFamide-related peptide (RFRP)-3 [also referred to as neuropeptide VF in mammals (7) and gonadotrophin-inhibitory hormone or GnIH in birds (5) ]. The Rfrp/Npvf gene produces two peptides in rodents, RFRP-1 and RFRP-3 (6) . These peptides share a common C-terminal LPXRFamide (X = L or Q) motif, making them part of the RFamide family of peptides, of which kisspeptin is also a member. The demonstration that GnIH is a potent inhibitor of gonadotrophin release in quails (5) spurred great interest in the roles of RFRP-1 and RFRP-3 in the regulation of endocrine functions in mammals. Because RFRP-3 (rather than RFRP-1) has also been shown to modulate gonadotrophin concentration in mammals, research has mainly focused on the role of RFRP-3 in the regulation of mammalian reproduction. Moreover, an initial study in rats indicating that RFRP-1 stimulated prolactin secretion, but not other pituitary hormones (6) , suggested that this peptide might be involved in the regulation of endocrine functions other than reproduction. The divergent effects of RFRP-1 and RFRP-3 agree with a study by Pineda et al. (8) , which showed that central RFRP-3, but not RFRP-1, inhibited serum LH concentration in rats. Both peptides act on the same receptors: GPR147 (also known as NPFFR1) and, to a lesser extent, GPR74 (NPFF2R), although RFRP-1 exhibits higher binding and agonistic activity for GPR74 than does RFRP-3 (7, 9) .
A large body of data now indicates that RFRP-3 is involved in the regulation of gonadotrophic activity in various mammalian species, including rats, hamsters, sheep, and cattle (10) (11) (12) (13) . This action presumably occurs via the RFRP-3 receptor GPR147 (also known as NPFF1R), which is expressed on subpopulations of both GnRH and kisspeptin neurons (14) . In females of several species, one important central reproductive effect of RFRP-3 may be suppression of the preovulatory surge of GnRH and LH that triggers ovulation (15) (16) (17) (18) , presumably to ensure its correct timing. Suppressive effects of RFRP-3 administration on LH secretion are less apparent under negative feedback conditions when LH levels are already low, but these effects are sometimes demonstrable in gonadectomized animals (19) (20) (21) . Other experiments (15, (21) (22) (23) (24) have failed to replicate these effects, however, and in two species of hamster RFRP-3 has exerted stimulatory effects (25, 26) . Although these discrepancies are not obviously reconciled by methodologic differences, there is a clear need for studies that systematically compare different RFRP-3 doses and routes of injection across different reproductive states and sexes. Furthermore, the data available on the role of RFRP-3 on gonadotrophin release in mice remain surprisingly scarce (27) (28) (29) , perhaps because of the difficulties of repeated blood sampling for analysis of gonadotrophin profiles in this small species. We therefore decided to carry out a comprehensive study of the effect of centrally and peripherally administered RFRP-3 on LH secretion in male and female mice, using frequent blood sampling and taking into account reproductive cycle stage.
Materials and Methods

Animals
C57BL/6J mice (aged 8 to 13 weeks and weighing 20 to 25 g) were obtained from the University of Otago animal breeding facility. For one experiment, similarly aged 129S6/ Sv/Ev KISS1R knockout (KISS1R KO) male mice and their wild-type littermate controls were used to test whether the response to RFRP-3 involved the kisspeptin receptor. These mice were pretreated with four priming injections of GnRH (4 nmol/kg, subcutaneous) spaced 4 hours apart, with the last injection given 24 hours before RFRP-3 treatment. This protocol allows the pituitary gland to become more responsive to GnRH in this mouse line, as previously reported (30) (31) (32) . Mice were individually housed under conditions of controlled lighting (lights on at 0600 hours, lights off at 1800 hours) and temperature (22°C 6 1°C) and had ad libitum access to standard rodent chow and water. In some of the experiments, the estrous cycle stage was determined by analyzing vaginal cytology daily for at least 8 days leading up to the time of experiment. Regularly cycling mice were used in the diestrus stage when a predominance of leukocytes was present, or in the proestrus stage when a predominance of nucleated cells was present, confirmed by a predominance of cornified cells the following day. The University of Otago Animal Ethics Committee approved all experimental protocols.
Intracerebroventricular RFRP-3 injections
Under 2% isoflurane anesthesia, mice were positioned in the stereotaxic apparatus. Once the head had been prepared and the skin incised, a stainless steel 23-gauge guide cannula (Plastics One, Roanoke, VA) was lowered to the lateral ventricle at 1 mm lateral to the midline, 0.8 mm posterior to the bregma, and 2.3 mm inferior to the dura matter. The cannula was fixed to the skull with light-activated dental cement and blocked with a dummy cannula (Plastics One). The animals were allowed a week to recover from the surgery. The RFRP-3 injections (rat RFRP-3; Bachem, Torrance, CA; 1 mL per animal injected over 2 minutes) were given to conscious, briefly restrained mice during blood sampling using a 30-gauge stainless steel internal cannula (Plastics One) attached to polyethylene tubing and a 2-mL Hamilton syringe (Hamilton Inc., Reno, NV).
Castration, ovariectomy, estradiol replacement, and preovulatory-like LH surge induction For one experiment, male mice were anesthetized under 2% isoflurane anesthesia, and bilateral castration (CAST) was carried out under sterile conditions. After at least 1 week the animals were placed in a stereotaxic apparatus and implanted with a guide cannula in the lateral ventricle as described previously.
For some of the experiments, female mice were anesthetized under 2% isoflurane anesthesia, and bilateral ovariectomy (OVX) was carried out under sterile conditions. All OVX mice were treated with an estradiol-filled silicone rubber capsule, 1.0-mm internal diameter, 2.1-mm external diameter (Dow Corning, Midland, MI), filled with medicalgrade silicone rubber adhesive (Dow Corning) containing 17b-estradiol (0.1 mg/mL adhesive; Sigma-Aldrich, St. Louis, MO) implanted subcutaneously. Each mouse was given a 1-cm-long capsule containing ;1 mg 17b-estradiol (SigmaAldrich). The animals were then placed in a stereotaxic apparatus and implanted with a guide cannula in the lateral ventricle as described previously.
In some of the experiments, to induce a preovulatory-like surge in female mice (33, 34) , OVX + estradiol (E2) mice received a subcutaneous injection of b-estradiol 3-benzoate (1 mg; Sigma-Aldrich) at 0900 hours, 6 days after ovariectomy. On the following day, mice received intracerebroventricular (ICV) RFRP-3 injections, and blood sampling was carried out in the late afternoon, at the surge peak time.
Hormone measurements
Repeated tail-tip blood samples (5 mL) were obtained from male mice (intact and CAST) and diestrus (or OVX, estradiolimplanted) female mice in the morning (between 1000 hours and 1200 hours). As previously described (35) , the preovulatory LH surge peaked at around 1830 hours on the day of proestrus in intact animals and around 1900 hours in OVX, surge-induced female mice. Repeated tail-tip blood samples (5 mL) were therefore obtained between 1800 hours and 2100 hours in intact proestrus females and between 1830 hours and 2130 hours in OVX, surge-induced females. Animals were blood sampled 10 minutes and immediately before treatment, and then at 5-to 15-minute intervals for at least 75 minutes after RFRP-3 treatment. Samples were diluted in 150 mL phosphatebuffered saline, and 50-mL aliquots were used for LH assay. Whole-blood LH concentrations were assessed in duplicate by using a sensitive sandwich enzyme-linked immunosorbent assay, as previously described (36) . The assay sensitivity averaged 0.1 ng/mL after correction for sample dilution, and the interand intra-assay coefficients of variation were ,5% and ,8%, respectively.
Statistical analyses
The LH values presented were corrected for the sample dilution in phosphate-buffered saline at the time of collection. Changes in circulating LH concentration in response to the RFRP-3 injections were calculated as area under the curve (AUC) for each mouse, using the average of the concentration 10 minutes and immediately before the injection as the baseline value. The AUC data were analyzed for treatment effects by using the Student t test and one-way or two-way analysis of variance as appropriate. Data are presented in graphs as mean 6 standard error of the mean.
Results
Central RFRP-3 dose-dependently stimulates LH secretion in intact male mice Two studies have indicated that RFRP-3 stimulates the gonadotrophic axis of male hamsters (25, 26) , suggesting that species or sex differences separate these from the published inhibitory effects of RFRP-3 (8, 17, 20, 21, (37) (38) (39) . To determine whether LH secretion in male mice is inhibited or stimulated by RFRP-3, the effect of ICV injections of RFRP-3 on LH secretion in male mice was tested. Surprisingly, RFRP-3 dose-dependently increased plasma LH levels to about three times baseline values, an effect that lasted at least 75 minutes [ Fig.  1(a) ]. Comparison of AUC values revealed that the maximal response was obtained with a 3-nmol dose of RFRP-3 (P , 0.0001 vs saline-treated controls) but both 0.5 nmol and 1 nmol also induced a significant increase in LH secretion (P , 0.001 vs saline-treated Fig. 1(b) ]. These data indicate that central RFRP-3 does not inhibit but rather activates the gonadotrophic axis of male mice, contrasting with the dogma of generalized inhibitory effects.
Central RFRP-3 dose-dependently stimulates LH secretion in CAST male mice Because of the profound sex differences in the effect of RFRP-3 on LH secretion in mice and hamsters, we decided to examine the involvement of gonadal steroids in males. To determine whether the increase in LH secretion in male mice in response to RFRP-3 depends on circulating levels of testosterone, we carried out ICV injections of RFRP-3 (0.5 nmol) in CAST animals. Similarly to the effect observed in intact males, RFRP-3 significantly increased plasma LH levels compared with the administration of vehicle (P , 0.01 compared with vehicle-treated mice) [ Fig. 2 (a) and 2(b)]. These data indicate that the stimulatory effect of central RFRP-3 on LH secretion in male mice does not depend on circulating levels of gonadal steroids.
Central RFRP-3 stimulates LH secretion, in part through the KISS1R in male mice
Because the results described previously are reminiscent of the stimulatory effect of kisspeptin on LH secretion, and because there is some limited evidence for a very weak affinity of RFRP-3 at the KISS1R (31), we sought to determine whether RFRP-3 might be able to stimulate the male mouse reproductive axis via this receptor. In this aim, we analyzed the effects of ICV injections of a stimulatory dose of RFRP-3 on LH secretion in male mice carrying a deletion of the KISS1R. As expected on the basis of the results of the previous experiment, administration of RFRP-3 (0.5 nmol) to the wildtype control littermates induced a significant increase in LH secretion compared with vehicle-treated mice (P , 0.05), and this effect was significantly reduced in magnitude in the KISS1R KO mice (wild-type RFRP-3 treated vs KISS1R KO RFRP-3 treated: P , 0.05) [ Fig. 3(a) and 3(b) ]. However, RFRP-3 (0.5 nmol) still induced a slight but significant increase in LH secretion in the KISS1R KO animals compared with the vehicle-injected wild-type littermates (P , 0.05). These results suggest that the stimulatory effect of RFRP-3 on LH secretion in male mice may be mediated, in part, through kisspeptin receptors.
Central RFRP-3 has no effect on LH secretion under E2-negative feedback conditions but can inhibit LH secretion during a preovulatory-like surge in female OVX mice
It has been hypothesized that the tone of the RFRP neuronal system might reduce on the afternoon of proestrus to permit the onset of estrogen-positive feedback and the consequent preovulatory GnRH/ LH surge (15, 16) . If this is the case, RFRP-3 administration might suppress the preovulatory surge but have no effect under negative feedback conditions when LH levels are low and its endogenous tone may already be maximal. Initially, we tested this in OVX + E2 mice with or without E2 benzoate surge induction, used to model negative and positive feedback conditions respectively. ICV administration of RFRP-3 (0.5 nmol) had no effect on LH secretion under negative feedback conditions [ Fig. 4(a) and 4(b) ]. These mice were later subjected to a preovulatory-like surge protocol, in which an LH surge is artificially induced to model the surge that occurs on the day of proestrus. As expected, vehicle-treated mice exhibited a robust LH surge, peaking about 90 minutes after the onset of the dark phase [ Fig. 4(c) ]. An ICV injection of RFRP-3 (0.5 nmol) largely prevented this rise in LH levels (P , 0.01 compared with Central RFRP-3 has no effect on LH secretion in diestrus, but inhibits LH secretion in proestrus at the time of the preovulatory LH surge in mice
We next determined whether this inhibitory effect of RFRP-3 in OVX mice, which was apparent when administered under E2-positive feedback conditions, would also occur during a natural preovulatory LH surge in intact cycling females. After having determined the estrous cycle stage by examining vaginal cytology, mice received an ICV injection of RFRP-3 (0.5 nmol) on the morning of diestrus or in the late afternoon on the day of proestrus. In diestrus, RFRP-3 had no effect on LH secretion [ Fig. 5(a) and 5(b) ], whereas RFRP-3 administration at the time of the preovulatory LH surge significantly dampened the surge magnitude (P , 0.01 compared with vehicle-treated mice) [ Fig. 5(c) and
. These data support the results obtained in OVX mice presented previously, and confirms that the effect of RFRP-3 on the female mouse reproductive axis varies depending on the stage of the estrous cycle at which it is administered.
Peripheral RFRP-3 has no effect on LH secretion in male and female mice It remains controversial whether RFRP-3 exerts hypophysiotrophic effects in mammals as reported in birds. A large body of evidence now reports the scarcity of fibers in the median eminence of various rodent species, including mice (22, 26, (40) (41) (42) (43) . We decided to test whether peripherally administered RFRP-3 could replicate the effects of ICV treatment reported previously in male and female mice, to determine whether this peptide can exert hypophysiotrophic actions in this species. When administered intraperitoneally to male mice, 10 nmol and 50 nmol of RFRP-3 had no effect on LH secretion compared with vehicle-injected controls [ Fig. 6(a) and 
Discussion
GnIH was discovered in birds in 2000 and termed accordingly because of its inhibitory effect on gonadotrophin secretion (5). Indeed, GnIH administration reduces plasma LH concentrations in vivo in quails and sparrows (5, 44, 45) and inhibits gonadotrophin synthesis and release in vitro from cultured quail and chicken pituitaries (45, 46) . Taken together, these data indicate that GnIH inhibits gonadotrophin synthesis and release in birds, likely via a direct inhibitory effect at the level of the pituitary.
This discovery led to intensive research on the possible roles of RFRP-3 in the regulation of the mammalian reproductive axis. Until recently, an inhibitory effect of the peptide was the main effect reported on the reproductive axis of mammals, including rats (8, 21, 37) and cattle (20) . In sheep, conflicting results have demonstrated either an inhibitory effect of RFRP-3 on LH secretion or no effect at all (17, 19, 23, 24, 39) , indicating that the effect of RFRP-3 on LH secretion is variable and might depend on the experimental conditions, although there are no obvious methodologic explanations for the disparities. In striking contrast, two studies published in 2012 in hamsters indicated that the effects of RFRP-3 might be species-or sex-dependent, as they reported stimulatory effects of the peptide on the gonadotrophic axis (25, 26) .
In the current study, we compared the effects of RFRP-3 in both males and females over a range of doses, injection routes, and reproductive states in an attempt to explain some of these variable effects. We used mice (seldom used in this field until now because of the difficulty of obtaining frequent blood samples required for comprehensive gonadotropin profiling) for these experiments to make use of gene knockout techniques. Our results show that RFRP-3 has a dose-dependent stimulatory effect on LH secretion in both intact and gonadectomized male mice, which supports the aforementioned findings from male hamsters, but is contrary to the dogma that kisspeptins and RFRP-3 always exert opposing effects on the reproductive axis. On the other hand, we show that the inhibitory effect in females is confined to the time of the preovulatory GnRH/LH surge, at least in the range of conditions we examined. These results indicate that the effects of RFRP-3 on LH secretion in males and females are differentially influenced by circulating levels of sex steroids, and perhaps by developmentally programmed sex-specifc neurocircuitry. Additional experiments, such as RFRP-3 injections in female mice masculinized by perinatal steroid treatments, might provide information on whether these sex-dependent effects are due to developmental neuroanatomical differences, or to ambient variations in circulating gonadal steroids. The fact that the male-specific stimulation of LH secretion by RFRP-3 was maintained at a similar magnitude following the removal of gonadal steroids provides evidence in support of the former explanation.
Because of the well-known stimulatory effect of kisspeptins on gonadotropin secretion and the potential for interaction between RFRP and kisspeptin neurons, we sought to determine whether RFRP-3 might stimulate the mouse reproductive axis by acting via kisspeptin receptors. The data obtained from our experiment of ICV injections of RFRP-3 in KISS1R KO mice indicates that the stimulatory effect of RFRP-3 on the male mouse reproductive axis is mediated through KISS1R, but only in part. However, it seems unlikely that this would occur as a direct effect of RFRP-3 on KISS1R, based on receptor pharmacology. RFRP-3 binds with high affinity to GPR147 (also known as NPFF1R) and with a lower affinity to GPR74 (also known as NPFF2R), which were first identified as neuropeptide FF receptors (6, 7, 9) . Because RFRPs are part of the same family of peptides as kisspeptins, which share a common C-terminal motif, it had been thought that these peptides might bind to receptors of other members of the RFamide family of peptides. However, a systematic study of the five cloned human RFamide receptors (NPFF1R, NPFF2R, GPR10, KISS1R, and GPR103) in terms of affinity and functional activity toward each endogenous RFamide neuropeptide showed that GPR147 and GPR74 displayed affinity for all the RFamide peptides, whereas GPR10, KISS1R, and GPR103 essentially only bind their cognate ligands (47) . With regard to KISS1R, the Ki value at this receptor for RFRP-3 is around 10,000 times that of kisspeptin itself (31) .
A more likely explanation for the KISS1R-dependant LH stimulation by RFRP-3 is that RFRP-3 could stimulate the kisspeptin neurons themselves. Although usually thought of as exerting an inhibitory action on the GnRH neuronal network, the GPR147 receptor couples with G ai3 or G as proteins (48), suggesting that it has the potential to exert both inhibitory and stimulatory downstream effects on cellular activity. Stimulatory effects of RFRP-3 have also been detected using electrophysiology in a small proportion of GnRH neurons (49) and have been proposed recently for corticotrophin releasing hormone neurons (31) . A subpopulation of arcuate kisspeptin neurons express the Gpr147 and Gpr74 genes and receive apparent contact from RFRP fibers in mice and rats (14, 50) , providing anatomic support for the potential of RFRP-3 to stimulate the reproductive axis via activation of kisspeptin neurons. Further studies will be required to test for such stimulatory effects on kisspeptin neurons, whether these are sex-specific, and what the hormonal or cellular determinants of such specificity are.
Although we have reported no obvious differences in the level of Gpr147 and Gpr74 expression in arcuate or periventricular kisspeptin or preoptic GnRH neurons in male or female mice (14, 50) , it is possible that the sexspecific effects of RFRP-3 on LH secretion presented in this study reflect the differences in kisspeptin neuronal populations themselves. In particular, the periventricular kisspeptin neuron population contains many times the number of cells in females compared with males, although only ;12% of these express Gpr147 in either sex (50) . With a view to better understanding the male-specific stimulatory LH response, effects of RFRP-3 should also be compared in males of other species because one study using male rats observed no stimulation (8) .
To date, the effect of RFRP-3 on the female gonadotrophic axis has usually been investigated in OVX animals, including rats (8, 21) , Syrian hamsters (25, 42) , and sheep (19, 24, 39) . The reason for this is most likely that LH concentrations in intact animals are maintained at low levels because of steroidal negative feedback, such that further suppression by RFRP-3 would be difficult to observe. In the current study, we show that RFRP-3 administration to OVX + E2 mice, used to model diestrus-like conditions, has no effect on LH secretion. Because the degree of LH suppression by our low-dose E2 implants was very moderate, we should have been able to detect any inhibitory effects of RFRP-3 had they occurred. Nevertheless, we cannot rule out the possibility that the absence of such an effect was simply due to LH already being close to basal levels. With regard to female mice, one recent study reported inhibitory effects of centrally administered RFRP-3 at doses similar to those used in the current study (29) , but only 4 hours after injection. In this study, the effect was seen in both OVX and OVX + E2 states.
In OVX mice subjected to a preovulatory-like surge protocol (in which an LH surge is artificially induced to model the proestrus surge), RFRP-3 administration greatly attenuated the increase in LH levels. This is in line with results published from a range of species, where central administration of RFRP-3 inhibits artificially induced preovulatory-like surges (15, 17, 18 ). In the current study, we confirmed that this effect also holds true for the preovulatory surge in naturally cycling females. Collectively, these findings suggest that the RFRP neuronal system might be involved in restraining the estrogen-mediated positive feedback, which regulates ovulation. Indeed, the number of RFRP neurons and their level of activity are decreased at the time of the LH surge in the Syrian hamster (16) . Furthermore, Rfrp messenger RNA expression is reduced in OVX mice treated with high-dose E2 (51) . However, a study in rats showed no difference in Rfrp messenger RNA levels of females that were diestrus, OVX, or OVX and treated with high-dose estrogen (52) , suggesting possible species-related differences. It is worth mentioning here that these hormonal manipulation protocols may not reflect normal physiologic conditions, and Rfrp gene expression and peptide levels should be measured throughout the natural cycle.
There are two possible explanations for the proestrusspecific inhibitory effect of RFRP-3. First, endogenous RFRP-3 levels may already be maximal during diestrus, and we were therefore unable to induce a stronger inhibition by treating with exogenous peptide. Alternatively, LH levels may be kept at basal levels during diestrus by other means, such as lack of kisspeptin drive, and can therefore not be inhibited further by RFRP-3 treatment. Techniques that enable excitation or silencing of RFRP neurons at different times of the cycle, combined with measurements of the dynamics of RFRP-3 release, will be required to determine which of these is the case.
It is already well established that the kisspeptin neurons in the arcuate and anteroventral periventricular hypothalamic nuclei are key components regulating the estrous cycle and are involved in the positive feedback effects of estrogen leading to the preovulatory LH surge (18) . It therefore appears that these two distinct neuronal populations, which produce structurally related peptides of the RFamide family, could both be central players in the mechanisms involved in generating the preovulatory LH surge. The combined inhibitory effect of RFRPs and stimulatory effect of kisspeptins might shape the LH secretion profile throughout the estrous cycle. The current study investigated the effect of RFRP-3 in an intact female rodent at different times of the reproductive cycle and provides clear evidence supporting a sex-and cycle stage-specific role of RFRP-3 in regulating the reproductive axis of mice.
There is still a debate on a potential hypophysiotrophic effect of RFRP-3 in mammals as reported in birds. A large body of evidence now reports the absence of fibers in the median eminence of mice, rats, hamsters, rhesus macaques, and possums (22, 26, 40, 41, 43) , although sparse RFRP fiber innervation in the median eminence has occasionally been reported in a few species (42, 53) . In OVX rats, intravenous administration of RFRP-3 significantly reduced plasma LH concentrations in one study (21) , whereas in another study the same protocol had no effect on basal LH secretion and minimal effects on GnRHstimulated secretion (22) . In vitro, RFRP-3 inhibited LH secretion from cultured pituitary cells when GnRH is present but did not have a significant effect on basal LH levels in the same study (21) . In another study, RFRP-3 did not have a direct suppressive effect on LH secretion in cultured rat anterior pituitary cells (15) . In OVX female Syrian hamsters, intraperitoneal injections of avian GnIH significantly inhibited LH secretion (42) , but in the male hamster RFRP-3 had no effect on LH secretion when injected peripherally, or on the basal or GnRHstimulated production of LH from isolated pituitary glands (25) . In our study, two doses of RFRP-3 had no effect on LH secretion in male and female mice when administered peripherally, suggesting that it is not a hypophysiotrophic peptide in mice. Given that our lowest interperitoneal dose was ;10 times higher than that used in the aforementioned hamster study (42), we cannot exclude the possibility that lower dose of RFRP-3 might have had an effect, but this seems unlikely. Although it is difficult to reconcile the range of reported responses to peripheral RFRP-3 treatment, where significant effects are seen they are very subtle compared with those we report here following central treatment at the time of the preovulatory surge. Thus, it appears that most if not all of the effects of RFRP-3 occur centrally in mice.
In sheep, on the other hand, RFRP fibers terminating in the median eminence have been identified and RFRP has been detected in the portal blood (19, 39, 54) . Moreover, in sheep and cattle, intravenous RFRP-3 administration inhibits gonadotrophin release (19, 20) , although another study failed to replicate these results in sheep (23) . These data suggest likely species-dependent differences in the modes of action of RFRP-3, and it is possible that sheep and rodents evolved this system differently.
This study provides a comprehensive description of the effects of RFRP-3 on the mouse gonadotrophic axis, taking into account the effects of sex, circulating levels of gonadal steroids, and central vs peripheral sites of action. In addition to the male-specific stimulatory effect that we identify in the current work, we show that the inhibitory role of RFRP-3 on the reproductive axis varies in female mice and is most pronounced at the time of the preovulatory LH surge. Additional studies will be required to determine whether these variations are due to differences in RFRP-3 fiber projections, receptor distribution, or signaling mechanisms.
